more_reports

Aptose Biosciences Inc.

APTO:NASDAQ

Aptose Biosciences is a clinical-stage biotechnology company. The company is engaged in the development of anticancer drugs that target specific epigenetic processes and signal transduction abnormalities that underlie a particular life-threatening malignancy. Its product pipeline includes cancer drug candidates that exert activity as stand-alone agents and that enhance the activities of other anticancer agents without causing overlapping toxicities.

streetwise book logo Streetwise Company Fact Sheet

2024/7/13 6:36:47

(APTO:NASDAQ)